Chlamydophila pneumoniae infection and COPD: More evidence for lack of evidence?

European Journal of Internal Medicine

Volumn 20, Issue 6, 2009, Pages 579-585

  Papaetis, Georgios S ^a   Anastasakou, Evgenia ^b   Orphanidou, Dora ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

Author keywords

Chlamydophila pneumoniae; COPD; Exacerbation; MIF

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

BACTERIUM CULTURE; BACTERIUM DETECTION; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; PATHOGENESIS; PREVALENCE; REVIEW;

ACUTE DISEASE; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; PNEUMONIA, BACTERIAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 70349296813     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2009.05.006     Document Type: Review

References (80)

1. Fujita M., and Nakanishi Y. The pathogenesis of COPD: lessons learned from in vivo animal models. Med Sci Monit 13 (2007) 19-24
2. Sethi S. Bacterial infection and the pathogenesis of COPD. Chest 117 (2000) 286-291
3. Hammerschlag M.R. The intracellular life of chlamydiae. Semin Pediatr Infect Dis 13 (2002) 239-248
4. Kumar S., and Hammerschlag M.R. Acute respiratory infection due to Chlamydia pneumoniae. Current status of diagnostic methods. Clin Infect Dis 44 (2007) 568-576
5. Meijer A., Roholl P.J., Gielis-Proper S.K., Muelenberg Y.F., and Ossewaarde J.M. Chlamydia pneumoniae in vitro and in vivo: a critical evaluation of in situ detection methods. J Clin Pathol 53 (2000) 904-910
6. Falsey A.R., and Walsh E.E. Transmission of Chlamydia pneumoniae. J Infect Dis 168 (1993) 493-496
7. Yang J., Hooper W.C., Phillips D.J., Tondella M.L., and Talkington D.F. Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection. Infect Immun 71 (2003) 614-620
8. Beatty W.L., Morrison R.P., and Byrne G. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 58 (1994) 686-699
9. Wolf K., Fischer F., and Hackstadt T. Ultrastructural analysis of development events in Chlamydia pneumoniae-infected cells. Infect Immun 68 (2000) 2379-2385
10. Malay S., Kohlhoff S., Roblin P.M., et al. Effect of acute and chronic Chlamydia pneumoniae infection on apoptosis in human respiratory epithelial cells. Pediatr Res 49 (2001) 250A
11. von Hertzen L.C. Chlamydia pneumoniae and its role in chronic obstructive pulmonary disease. Ann Med 30 (1998) 27-37
12. Emre U., Roblin P.M., Gelling M., et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 148 (1994) 727-732
13. Tsumura N., Emre U., Roblin P., and Hammeschlag M.R. Effect of hydrocortisone succinate on growth of Chlamydia pneumoniae in vitro. J Clin Microbiol 34 (1996) 2379-2381
14. Pomerleau O.F., and Pomerleau C.S. Cortisol response to a physiological stressor and/or nicotine. Pharmacol Biochem Behav 36 (1990) 211-213
15. von H.L. Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae. Eur Respir J 19 (2002) 546-556
16. Ward M.E. An update on the immunology of chlamydial infection. In: Stary A. (Ed). Proceedings of the 3rd Meeting of the European Society for Chlamydia Research (1996), Societa Editrice Esculapio, Bologna 58-62
17. Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect 25 suppl. 1 (1992) 27-34
18. Saikku P., Leinonen M., Tenkanen L., et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 116 (1992) 273-278
19. Roblin P.M., Dumomay W., and Hammerschlag M.R. Use of HEp-2 cells for improved isolation and passage of Chlamydophila pneumoniae. J Clin Microbiol 30 (1992) 1968-1971
20. Grayston J.T., Campbell L.A., Kuo C.C., et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 161 (1990) 618-625
21. Dowell S.F., Boman J., Carlone G.M., et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA), and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 33 (2001) 492-503
22. Gencay M., and Roth M. Chlamydia pneumoniae infections in asthma: clinical implications. Am J Respir Med 2 (2003) 31-38
23. Apfalter P., Assadian O., Blasi F., et al. Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols. J Clin Microbiol 40 (2002) 4428-4434
24. Thomas M., Wong Y., Thomas W., et al. Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque. Circulation 99 (1999) 2733-2736
25. Beaty C.D., Grayston J.T., Wang S.P., Kuo C.C., Reto C.S., and Martin T.R. Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 144 (1991) 1408-1410
26. von Hertzen L., Isoaho R., Leinonen M., et al. Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease. Int J Epidemiol 25 (1996) 658-664
27. Blasi F., Legnani D., Lombardo V.M., et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J 6 (1993) 19-22
28. Miyashita N., Niki Y., Nakajima M., Kawane H., and Matsushima T. Chlamydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD. Chest 114 (1998) 969-971
29. Goh S.K., Johan A., Cheong T.H., and Wang Y.T. A prospective study of infections with atypical pneumonia organisms in acute exacerbations of chronic bronchitis. Ann Acad Med Singapore 28 (1999) 476-480
30. Mogulkoc N., Karakurt S., Isalska B., et al. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am J Respir Crit Care Med 160 (1999) 349-353
31. Lieberman D., Ben-Yaakov M., Lazarovich Z., Ohana B., and Boldur I. Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease: analysis of 250 hospitalizations. Eur J Clin Microbiol Infect Dis 20 (2001) 698-704
32. Meloni F., Paschetto E., Mangiarotti P., et al. Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations. J Chemother 16 (2004) 70-76
33. Soler N., Torres A., Ewig S., et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 157 (1998) 1498-1505
34. Diederen B.M., van der Valk P.D., Kluytmans J.A., Peeters M.F., and Hendrix R. The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease. Eur Respir J 30 (2007) 240-244
35. Karnak D., Beng-sun S., Beder S., and Kayacan O. Chlamydia pneumoniae infection and acute exacerbation of chronic obstructive pulmonary disease (COPD). Respir Med 95 (2001) 811-816
36. Seemungal T.A., Harper-Owen R., Bhowmik A., et al. Respiratory viruses, symptoms and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 1618-1623
37. Blasi F., Damato S., Cosentini R., et al. Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax 57 (2002) 672-676
38. Seemungal T.A., Wedzicha J.A., MacCallum P.K., Johnston S.L., and Lambert P.A. Chlamydia pneumoniae and COPD exacerbation. Thorax 57 (2002) 1087-1088
39. Papaetis G.S., Anastasakou E., Tselou T., et al. Serological diagnosis of Chlamydophila pneumoniae infection in Greek COPD patients by microimmunofluorescence and ELISA. Med Sci Monit 14 (2008) 27-35
40. Hyman C.L., Roblin P.M., Gaydos C.A., Quinn T.C., Schachter J., and Hammerschlag M.R. The prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 20 (1995) 1174-1178
41. Hammerschlag M.R. Chlamydia pneumoniae and asthma in children: diagnostic issues. Clin Infect Dis 39 (2004) 1251-1252
42. Hammerschlag M.R. Asymptomatic respiratory infection with Chlamydia pneumoniae. What does it mean?. Chest 119 (2001) 1303-1305
43. Peeling R.W., Wang S.P., Grayston J.T., et al. Chlamydia pneumoniae serology: interaboratory variation in microimmunofluorescence assay results. J Infect Dis 181 Suppl 3 (2000) S426-S429
44. Littman A.J., Jackson L.A., White E., Thornquist M.D., Gaydos C.A., and Vaughan T.L. Interlaboratory reliability of microimmunofluorescence test for measurement of Chlamydia pneumoniae-specific immunoglobulin A and G antibody titers. Clin Diagn Lab Immunol 11 (2004) 615-617
45. Verkooyen R.P., Willemse D., Hiep-van Casteren S.C., et al. Evaluation of PCR, culture and serology for diagnosis of Chlamydia pneumoniae respiratory infections. J Clin Microbiol 36 (1998) 2301-2307
46. Hermann C., Gueinzius K., Oehme A., Von Aulock S., Straube E., and Hartung T. Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections. J Clin Microbiol 42 (2004) 2476-2479
47. Hoymans V.Y., Bosmans J.M., Van Renterghem L., et al. Importance of methodology in determination of Chlamydia pneumoniae seropositivity in healthy subjects and in patients with coronary atherosclerosis. J Clin Microbiol 41 (2003) 4049-4053
48. Gutierrez J., Mendoza J., Fernandez F., Linares-Palomino J., Soto M.J., and Maroto M.C. ELISA test to detect Chlamydophila pneumoniae IgG. J Basic Microbiol 42 (2002) 13-18
49. Dean D., Roblin P.M., Mandel L., et al. Molecular evaluation of serial isolates from patients with persistent Chlamydia pneumoniae infection. In: Stephens R.S., Byrne G.I., and Christiansen G.I. (Eds). Chlamydial infections. Proceedings of the Ninth International Symposium on Human Chlamydial Infection (1998), University of California San Francisco, San Francisco, CA 219-222
50. Miyashita N., Niki Y., Nakajima M., Fukano H., and Matsushima T. Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults. Chest 119 (2001) 1416-1419
51. Y. Shemer-Anvi, D. Lieberman, Chlamydia pneumoniae-induced ciliostasis in ciliated epithelial cells. J Infect Dis 171: 1274-1278.
52. Mills G.D., Oehley M.R., and Arrol B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ 330 7489 (2005) 456
53. Miyashita N., Obase Y., Fukuda M., et al. Evaluation of diagnostic usefulness of real-time PCR for detection of Chlamydophila pneumoniae in acute respiratory infections. J Infect Chemother 13 (2007) 183-187
54. Loens K., Beck T., Ursi D., Pattyn S., Goossens H., and Ieven M. Two quality control exercises involving nucleic acid amplification methods for detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae and carried out 2 years apart (in 2002 and 2004). J Clin Microbiol 44 (2006) 899-908
55. Kuoppa Y., Boman J., Scott L., Kumlin U., Eriksson I., and Allard A. Quantitative detection of respiratory C. pneumoniae infection by real-time PCR. J Clin Microbiol 40 (2002) 2273-2274
56. Peeling R.W., Bailey R.L., Conway D.J., et al. Antibody response to the 60-kDa chlamydial heat-shock protein is associated with scarring trachoma. J Infect Dis 177 (1998) 256-259
57. Eckert L.O., Hawes S.E., Wölner-Hanssen P., et al. Prevalence and correlates of antibody to chlamydial heat shock protein in women attending sexually transmitted disease clinics and women with confirmed pelvic inflammatory disease. J Infect Dis 175 (1997) 1453-1458
58. Kol A., Sukhova G.K., Lichtman A.H., and Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression. Circulation 98 (1998) 300-307
59. Libby P., Sukhova G., Lee R.T., and Galis Z.S. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 25 Suppl 2 (1995) S9-12
60. Papaetis G.S., Roussos C., and Syrigos K.N. Targeted therapies for non-small cell lung cancer. Curr Pharm Des 13 (2007) 2810-2831
61. Finlay G.A., O'Driscoll L.R., Russell K.J., et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 156 (1997) 240-247
62. Yang J., Hooper W.C., Phillips D.J., Tondella M.L., and Talkington D.F. Induction of proinflammatory cytokines in human lung epithelial cells infected with Chlamydia pneumoniae. Infect Immun 71 (2003) 614-620
63. Bureau F., Bonizzi G., Kirschvink N., et al. Correlation between nuclear factor-κB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma. Am J Respir Crit Care Med 161 (2000) 1314-1321
64. Rödel J., Woytas M., Groh A., et al. Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae. Infect Immun 68 (2000) 3635-3641
65. Blasi F., Aliberti S., Allegra L., et al. Chlamydphila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice. Respir Res 8 (2007) 83
66. Gieffers J., van Zandbergen G., Rupp J., et al. Phagocytes transmit Chlamydia pneumoniae from the lung to the vasculature. Eur Respir J 23 (2004) 506-510
67. Gieffers J., Fullgraft H., Jahn J., et al. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 103 (2001) 351-356
68. May A.E., Redecke V., Grüner S., et al. Recruitment of Chlamydia pneumoniae-infected macrophages to the carotid artery wall in noninfected, nonatherosclerotic mice. Arterioscler Thromb Vasc Biol 23 (2003) 789-794
69. Blasi F., Boman J., Esposito G., et al. Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection. J Infect Dis 180 (1999) 2074-2076
70. Blasi F., Cosentini R., Tarsia P., et al. Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of bronchial chronic infection. Am J Respir Crit Care Med 161 (2000) A305
71. Boman J., and Hammerschlag M.R. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev 15 (2002) 1-20
72. West S.K., Kohlhepp S.J., Jin R., Gleaves C.A., Stamm W., and Gilbert D.N. Detection of circulating Chlamydophila pneumoniae in patients with coronary artery disease and healthy control subjects. Clin Infect Dis 48 (2009) 560-567
73. Smieja M., Leigh R., Petrich A., et al. Smoking, season, and detection of Chlamydia pneumoniae DNA in clinically stable COPD patients. BMC Infect Dis 2 (2002) 12
74. Apfalter P., Boman J., Nehr M., et al. Application of blood-based polymerase chain reaction for detection of Chlamydia pneumoniae in acute respiratory tract infections. Eur J Clin Microbiol Infect Dis 20 (2001) 584-586
75. Von Hertzen L., Alakärppä H., Koskinen R., et al. Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect 118 (1997) 155-164
76. Strachan D.P., Carrington D., Mendall M., Butland B.K., Yarnell J.W., and Elwood P. Chlamydia pneumoniae serology, lung function decline, and treatment for respiratory disease. Am J Respir Crit Care Med 161 (2000) 493-497
77. Kurashima K., Kanauchi T., Takayanagi, et al. Serum IgG and IgA antibodies to Chlamydia pneumoniae and severity of emphysema. Respirology 10 (2005) 572-578
78. Branden E., Koyi H., Gnarpe J., Gnarpe H., and Tornling G. Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD. Respir Med 99 (2005) 20-26
79. Hahn D., and Saikku P. Serological evidence of Chlamydia pneumoniae infection in recently symptomatic asthma: a pilot case-control study. Am J Respir Crit Care Med 151 (1995) A470 (suppl, Second of two parts)
80. Seemungal T.A., Donaldson G.C., Paul E.A., Bestall G.C., Jeffries D.J., and Wedzicha J.A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1418-1422